StockLearn from Clustermicro · Stock Breakout ScannerStockLearn
← US stocks and world indices

Vertex Pharmaceuticals (VRTX)

US-listed stock · Healthcare · Biotechnology · close 17 Nov 2026
Close
$534.20
Day change
-0.7%
1 month
+6.9%
6 months
+22.3%
1 year
+23.1%
3 years
+52.4%
5 years
+183.8%
From 52-week high
-4.4%
Weinstein stage
Stage 2
advancing
Vertex Pharmaceuticals closed at $534.20 on 17 Nov 2026. Over the past year it has gained 23.1%, and over five years +184% in all (+23.2% a year). It is 4.4% below its 52-week closing high of $558.88, set on 30 Oct 2026, and 26.9% above its 52-week closing low of $421.03. The price is above its 200-day average of $483.99 - an average that is itself still rising. On Stan Weinstein's stage analysis it is in Stage 2: advancing - above a rising 150-day average. Its deepest fall from a peak in the period shown was 29%. At that price it trades at 34.3 times its last twelve months' earnings ($15.58 a share, to 30 Sep 2026); net income changed +8% on a year earlier. On revenue of $13.0B (+10.5% on a year earlier), the net margin was 30.7%.

Valuation and profitability

Market value
$136.3B
P/E (TTM)
34.3
Price / book
6.5
Net margin
30.7%
Return on equity
19.0%
Revenue growth
+10.5%
Net income growth
+8%

From the company's SEC filings: the last twelve months to 30 Sep 2026, built from its 10-K and 10-Q reports. P/E and market value use the 17 Nov 2026 close, with the latest quarter's diluted share count; P/E is market value over net income, which stays right through a stock split. Growth compares with the twelve months a year earlier.

Price, RSI and MACD

Price · +24.1% over the period
417455492529567May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
RSI (14) · 50.4
305070
MACD (12, 26, 9) · histogram -1.44
-8.5-0.77.215.123
Price · +23.1% over the period
413451490529567Nov 25Jan 26Mar 26May 26Jul 26Sep 26Nov 26
RSI (14) · 50.4
305070
MACD (12, 26, 9) · histogram -1.44
-11.6-2.95.814.523.2
Price · +8.0% over the period
355408462515568Nov 24Mar 25Jul 25Nov 25Mar 26Jul 26Nov 26
RSI (14) · 50.4
305070
MACD (12, 26, 9) · histogram -1.44
-24.8-12.8-0.811.223.2
Price · +41.0% over the period
330390450510570Nov 23Apr 24Sep 24Feb 25Jul 25Dec 25May 26Oct 26
RSI (14) · 50.4
305070
MACD (12, 26, 9) · histogram -1.44
-24.2-12.4-0.511.323.2
Price · +184.3% over the period
164267370472575Aug 22May 23Feb 24Nov 24Aug 25May 26
RSI (14) · 50.4
305070
MACD (12, 26, 9) · histogram -1.44
-24.9-12.6-0.411.924.2
Price: daily close adjusted for stock splits, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

50-day average $522.31 · 200-day average $483.99 · 52-week closing range $421.03 – $558.88

Other Healthcare stocks

NameClose1M1Y5YP/EStage
Merck$143.37-1.8%+54.4%+73.6%144.82
Johnson & Johnson$278.70+9.1%+39.6%+70.7%42.42
Eli Lilly$1,415.55+12.6%+38.5%+442.0%45.92
Gilead Sciences$170.26+9.0%+37.2%+152.4%loss2
Regeneron Pharmaceuticals$957.76+21.1%+36.0%+49.2%21.02
Amgen$457.93+5.9%+34.0%+122.5%26.62
Elevance Health$433.93+1.3%+31.1%+1.0%18.42
Bristol Myers Squibb$61.35+2.7%+31.1%+3.2%13.62
McKesson$1,091.67+8.6%+27.6%+387.7%27.12
AbbVie$292.82+2.6%+25.1%+149.5%50.22
UnitedHealth$389.68-2.9%+21.6%-13.2%22.12
Thermo Fisher$686.79-0.5%+21.1%+7.8%36.02
Pfizer$28.47-3.8%+13.5%-44.0%40.62
CVS Health$85.81-7.1%+9.4%-7.5%10.03
Medtronic$102.32+8.0%+6.3%-13.2%25.12
HCA Healthcare$501.19+9.2%+5.0%+105.5%16.11
Danaher Corporation$225.77-1.4%+2.4%-17.8%36.82
Stryker Corporation$317.54+7.8%-11.8%+21.2%33.71
Abbott Laboratories$104.71-0.2%-19.5%-18.6%38.72
Intuitive Surgical$430.53+0.9%-21.3%+19.1%51.21

← All US stocks and world indices · NSE stocks

Daily closes to 17 Nov 2026, adjusted for stock splits (not dividends), from Google Finance and Yahoo Finance. US stock prices in US dollars; index levels in points. Figures may be delayed and are for information only.
For research & education only — not investment advice or a recommendation to buy or sell any security. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by any exchange or index provider. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.